Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

C10orf32 Activators

C10orf32 (BLOC-1 related complex subunit 7) is a component of the biogenesis of lysosome-related organelles complex-1 (BLOC-1), which plays a role in the trafficking and sorting of proteins to lysosome-related organelles. Certain chemicals have been identified that can enhance the functional activity of C10orf32 through diverse mechanisms that converge on the modulation of intracellular signaling molecules. These activators primarily work through the elevation of intracellular cyclic AMP (cAMP), which serves as a secondary messenger in various signaling pathways. Enhanced levels of cAMP typically activate protein kinase A (PKA), a key regulator of numerous cellular processes. The activation of PKA can lead to the phosphorylation of target proteins, which may include C10orf32, thereby modulating its functional activity within the cell.

The upstream stimulation of cAMP levels can occur through several mechanisms, including the activation of G-protein coupled receptors, inhibition of phosphodiesterases, or adrenergic receptor stimulation. Chemicals that function as beta-adrenergic agonists or inhibitors of specific phosphodiesterase isoforms can lead to an increase in cAMP, which in turn activates PKA. The subsequent PKA-mediated phosphorylation may influence the activity of C10orf32, thereby potentially enhancing its role within the BLOC-1 complex. In addition to these mechanisms, other compounds can indirectly affect cAMP levels by modulating related signaling molecules like cGMP.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

Non-specific inhibitor of phosphodiesterases, increases cAMP and cGMP by preventing their degradation, potentially enhancing PKA activity and leading to the phosphorylation of C10orf32.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$40.00
$102.00
$197.00
$1739.00
$16325.00
(1)

Stimulates adrenergic receptors, leading to increased cAMP production, which could activate PKA and promote the phosphorylation of C10orf32.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$27.00
$37.00
5
(0)

Beta-adrenergic agonist that increases cAMP levels, which may lead to the activation of PKA and the subsequent phosphorylation and activation of C10orf32.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$56.00
$156.00
$270.00
$665.00
37
(1)

Activates G-protein coupled receptors, which increases cAMP levels, potentially leading to PKA activation and phosphorylation of C10orf32.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$75.00
$212.00
18
(1)

Phosphodiesterase-4 inhibitor, increases cAMP levels, which may lead to PKA activation and subsequent phosphorylation of C10orf32.

Cilostamide (OPC 3689)

68550-75-4sc-201180
sc-201180A
5 mg
25 mg
$90.00
$350.00
16
(1)

Phosphodiesterase-3 inhibitor, raises cAMP levels, potentially leading to PKA activation and phosphorylation of C10orf32.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$103.00
$245.00
8
(2)

Inhibitor of phosphodiesterase-5, elevates cGMP levels, which might indirectly influence cAMP levels and lead to PKA-mediated phosphorylation of C10orf32.

Anagrelide

68475-42-3sc-491875
25 mg
$147.00
(0)

Inhibits phosphodiesterase-3, increases cAMP levels, which may lead to PKA activation and phosphorylation of C10orf32.

Dobutamine

34368-04-2sc-507555
100 mg
$295.00
(0)

Beta-adrenergic agonist, increases cAMP production, potentially leading to PKA activation and phosphorylation of C10orf32.

Milrinone

78415-72-2sc-201193
sc-201193A
10 mg
50 mg
$162.00
$683.00
7
(0)

Selective phosphodiesterase-3 inhibitor, increases cAMP levels, which could lead to PKA activation and phosphorylation of C10orf32.